Gerardo Hernandez
Patrimonio netto: 201 264 $ in data 31/05/2026
Patrimonio netto: 201 264 $ in data 31/05/2026
Gerardo Hernandez is currently Chief Financial Officer & Treasurer at TransMedics Group, Inc. since 2024.
Formerly, Mr. Hernandez was VP-Finance & Head-Financial Planning & Analysis at Alnylam Pharmaceuticals, Inc. from 2020 to 2024.
Education includes an MBA from Escola de Administração de Empresas de São Paulo and an undergraduate degree from the University of Wisconsin La Crosse.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 2.995 ( 0,01% ) | 201 264 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Direttore Finanziario/CFO | 02/12/2024 |
| Società | Posizione | Fine |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Escola de Administração de Empresas de São Paulo
Escola de Administração de Empresas de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin La Crosse
University of Wisconsin La Crosse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale